Abstract
This study was performed to investigate the attack-free complaints of patients with familial Mediterranean fever (FMF) and the impact of colchicine on these symptoms and on subclinical inflammation. A questionnaire that includes information about the disease course and symptoms during the attack-free period was administered to the parents of 50 FMF patients. For evaluation of the attack-free period, questions were asked about four items concerning daily activities of the children—weakness, lack of appetite, sleep problems, and decreased activity. The respondents rated the items and the total score was taken as the sum of all of the specific items. The laboratory values were noted from the patients’ files. During the attack-free period, patients with mild disease had higher total scores, higher weakness, and decreased activity scores than patients with moderate disease. When we compared the daily activity scores before and after colchicine therapy, a statistically significant increase was observed in the total scores and in all of the specific item scores. Also a significant decrease was seen in the erythrocyte sedimentation rate and white blood cell counts, and a significant increase was seen in the hemoglobin levels during the attack-free period after colchicine usage. Regression of inflammation together with improvement in daily activities were observed. FMF patients seem to have complaints during the attack-free period that may be related to subclinical inflammation. Moreover, colchicine besides preventing the FMF attacks and the dangerous complication ol amyloidosis also seems to hinder the symptoms of the attack-free period in children with FMF.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227–253
Yalçinkaya F, Turner N, Tekin M, Çakar N, Akçakus M (1997) Familial Mediterranean fever in Turkish children (analysis of 110 cases). In: Sohar E, Gafni J, Pras M (eds) First International Conference on Familial Mediterranean Fever (FMF) (abstract book). Freund Publishing House, London, pp 157–161
The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31
Majeed HA, Rawashdeh M, El-Shanti H, Quabain H, Khuribulos N, Shahin HM (1999) Familial Mediterranean fever in children: the expanded clinical profile. Q J Med 92:309–318
Goldfinger SE (1972) Colchicine for familial Mediterranean fever. N Engl J Med 287:1302
Özkan E, Okur Ö, Ekmekçi A, Özcan R, Tag T (1972) A new approach to the treatment of periodic fever. Med Bull Istanbul 5:44–49
Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:932–934
Zemer D, Livneh A, Danon YL, Pras M, Sohar E (1991) Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 34:973–977
Ben-Chetrit E, Levy M (1991) Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum 20:241–246
Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659–664
Tunca M, Kirkali G, Soytürk M, Akar S, Pepys MB, Hawkins PN (1999) Acute phase response and evolution of familial Mediterranean fever. Lancet 353:1415
Korkmaz C, Özdogan H, Kasapçopur Ö, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Establishment of a new set of criteria for the classification of familial Mediterranean fever. In: Sohar E, Gafni J, Pras M (eds) First international conference on familial Mediterranean fever (FMF) (abstract book). Freund Publishing House, London, pp 203–208
Özkaya N, Yalçinkaya F (2003) Colchicine treatment in children with familial Mediterranean fever. Clin Rheumatol 22:314–317
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online: 20 September 2005
Rights and permissions
About this article
Cite this article
Özcakar, Z.B., Yalçinkaya, F., Yüksel, S. et al. Possible effect of subclinical inflammation on daily life in familial Mediterranean fever. Clin Rheumatol 25, 149–152 (2006). https://doi.org/10.1007/s10067-005-1148-z
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-1148-z